What Is Actually in a CJC-1295 and Ipamorelin Vial
Run a spectrum of this vial and the ipamorelin ion turns up around m/z 712.9, wedged between two charge states belonging to its far larger partner: the five-plus near 674.6, the four-plus near 843.0. Judge by position alone, especially through a narrow scan window, and the reading can go wrong. Judge by isotope spacing and the ambiguity lasts about a second.
That is the one place a reader of this pairing can stumble. Everything else about it is easy: a 29-residue peptide and a 5-residue peptide in one container, separated by a mass ratio close to five to one.
Charge comes from spacing, never from position
Being small, ipamorelin gives electrospray little to work with, and the singly protonated species dominates. The other component, 3367.9 daltons of it, spreads across an envelope instead — five-plus near m/z 674.6, four-plus near 843.0, three-plus near 1123.6.
Once isotopes are visible the two are trivial to tell apart. Spacing of 1.0 on the m/z axis means one charge. Spacing of 0.2 means five. Where the ion sits never enters into it. The habit generalizes well beyond this vial: a spectrum published at resolution too coarse to show an isotope envelope has left out the evidence that assigns charge, and every assignment drawn from it is really a guess about position.
The two molecules behind those ions
Ten milligrams on the label means five of each, combined in solution and lyophilized together.
| Component | Sequence or descriptor | Formula | Mass | CAS |
| CJC-1295 without DAC, also written Mod GRF 1-29 | [D-Ala2, Gln8, Ala15, Leu27]-GRF(1-29) amide | C152H252N44O42 | 3367.9 g/mol | 863288-34-0 |
| Ipamorelin | Aib-His-D-2-Nal-D-Phe-Lys-NH2 | C38H49N9O5 | 711.9 g/mol | 170851-70-4 |
An amide caps the C-terminus in both cases. Note also that the first row is not interchangeable with the version carrying the drug-affinity complex, a separate molecule weighing roughly 3,647 g/mol; CJC-1295 with and without DAC lays out where they part company.
Nothing in common except the container
Two takes on one design these are not. One descends from a 44-residue endogenous releasing hormone, cut down to a fragment, edited in four places and finished with a terminal amide, each alteration aimed at a degradation route the native sequence is open to. The other was drawn up from nothing as a pentapeptide, assembled largely from residues proteins never use, and resembling no endogenous molecule whatever. Why the two families get conflated so regularly is the subject of GHRH analogs versus growth hormone secretagogues.
What ultraviolet settles and what it leaves open
Unusually, both components absorb at 280 nm, and the opportunity is worth taking. Tyrosines occupy positions 1 and 10 of Mod GRF 1-29. Ipamorelin contributes the naphthalene ring of its D-2-naphthylalanine, which absorbs strongly across the same region, with histidine and D-phenylalanine beside it.
Record at 280 nm alongside 214 nm, then, and every peak acquires a ratio between two areas, which is one more piece of identity evidence. Most blends cannot manage this. At least one component is usually dark at 280 nm, and the moment that happens the dual-wavelength comparison stops telling anyone anything.
Composition is the thing those areas will not deliver. At 214 nm, response tracks the number of backbone amide bonds, and the counts here are 28 against 4. Equal masses therefore yield badly unequal areas, with the large peptide swamping the trace. Fifty-fifty by mass will not present as fifty-fifty by area at any wavelength, and crossing from one to the other requires response factors measured against reference standards. The general form of the problem sits in what one vial of several compounds can and cannot tell you.
The question neither instrument can reach
Three residues in this vial are D-configured: D-2-naphthylalanine and D-phenylalanine within the pentapeptide, D-alanine at position 2 of the longer chain. Flip any one of them and what results is a diastereomer whose formula has not changed and whose mass has not changed either.
Hydrolyze the material and run amino acid analysis and the answer covers what is present, not how it is arranged in space. The mass spectrometer is equally blind. Settling it takes a chiral method, or a separation capable of pulling diastereomers apart, and routine certificates rarely include either. Racemization and chiral purity goes further into it.
What a lot record has to show
Both masses seen, 3367.9 and 711.9, their charge states assigned from isotope spacing rather than inferred from where the peaks landed. A chromatogram whose two peaks are pinned to standards, taken at two wavelengths where that is possible, and here it is. Milligrams stated per component instead of a single number for the vial. Either compound can also be had by itself — CJC-1295 without DAC, ipamorelin — when a study needs one and not the other.